Literature DB >> 18832038

Dopamine receptor 3 (D3) knockout mice show regular emotional behaviour.

S Chourbaji1, C Brandwein, M A Vogt, C Dormann, R Mueller, K U Drescher, G Gross, P Gass.   

Abstract

The "Dopamine Deficiency Hypothesis" and a considerable number of recent pharmacological studies propose to thoroughly verify and improve the standard of knowledge regarding a possible role of dopamine in the pathogenesis and treatment of depression. To elucidate the potential role of D3 receptors in the development of a depressive-like phenotype, we subjected D3 receptor knockout mice to a series of selected behavioural paradigms particularly focussing on depressive-like traits. In our experimental design we exposed animals with a deficiency of the D3 receptor (D3-/-) to a standardised behavioural test battery, in which general changes of locomotion, exploration, anxiety and depressive-like characteristics (i.e. Learned Helplessness, Sucrose Consumption and Forced Swim test) can be detected. Thorough behavioural phenotyping, however, neither revealed behavioural consequences on the basal level (locomotion, exploration) nor depressive- or anxiety-like alterations. Hence, these results do not indicate an evident involvement of the D3 receptor in the development of a depression-like syndrome in mice for now. This does, however, not exclude the D3 receptor as a potential target for pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18832038     DOI: 10.1016/j.phrs.2008.09.002

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  13 in total

1.  Alterations in postnatal neurogenesis and dopamine dysregulation in schizophrenia: a hypothesis.

Authors:  Dragos Inta; Andreas Meyer-Lindenberg; Peter Gass
Journal:  Schizophr Bull       Date:  2010-11-19       Impact factor: 9.306

2.  Dopamine D₂-Like Receptors and Behavioral Economics of Food Reinforcement.

Authors:  Paul L Soto; Takato Hiranita; Ming Xu; Steven R Hursh; David K Grandy; Jonathan L Katz
Journal:  Neuropsychopharmacology       Date:  2015-07-24       Impact factor: 7.853

Review 3.  Rationale in support of the use of selective dopamine D₃ receptor antagonists for the pharmacotherapeutic management of substance use disorders.

Authors:  Christian Heidbreder
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2012-10-28       Impact factor: 3.000

Review 4.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

Review 5.  The potential role of dopamine D₃ receptor neurotransmission in cognition.

Authors:  Shinichiro Nakajima; Philip Gerretsen; Hiroyoshi Takeuchi; Fernando Caravaggio; Tiffany Chow; Bernard Le Foll; Benoit Mulsant; Bruce Pollock; Ariel Graff-Guerrero
Journal:  Eur Neuropsychopharmacol       Date:  2013-06-20       Impact factor: 4.600

Review 6.  Medication discovery for addiction: translating the dopamine D3 receptor hypothesis.

Authors:  Amy Hauck Newman; Brandi L Blaylock; Michael A Nader; Jack Bergman; David R Sibley; Phil Skolnick
Journal:  Biochem Pharmacol       Date:  2012-07-03       Impact factor: 5.858

Review 7.  The neurobiology of anhedonia and other reward-related deficits.

Authors:  Andre Der-Avakian; Athina Markou
Journal:  Trends Neurosci       Date:  2011-12-15       Impact factor: 13.837

8.  Increased hippocampal CREB phosphorylation in dopamine D3 receptor knockout mice following passive avoidance conditioning.

Authors:  Agata Grazia D'Amico; Soraya Scuderi; Gian Marco Leggio; Alessandro Castorina; Filippo Drago; Velia D'Agata
Journal:  Neurochem Res       Date:  2013-10-08       Impact factor: 3.996

Review 9.  A behavioral genetics approach to understanding D1 receptor involvement in phasic dopamine signaling.

Authors:  Valerie Z Wall; Jones G Parker; Jonathan P Fadok; Martin Darvas; Larry Zweifel; Richard D Palmiter
Journal:  Mol Cell Neurosci       Date:  2010-10-01       Impact factor: 4.314

10.  Implication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.

Authors:  S Carnicella; G Drui; S Boulet; C Carcenac; M Favier; T Duran; M Savasta
Journal:  Transl Psychiatry       Date:  2014-06-17       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.